Exhibit 5.1

 

[Cooley Letterhead]

 

June 21, 2013

 

Rigel Pharmaceuticals, Inc.

1180 Veterans Boulevard

South San Francisco, CA 94080

 

Ladies and Gentlemen:

 

You have requested our opinion with respect to certain matters in connection with the filing by Rigel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), of a Registration Statement on Form S-8 (the “Registration Statement”) with the U.S. Securities and Exchange Commission covering the offering of up to seven million seven hundred seventy-five thousand (7,775,000) shares (the “Shares”) of the Company’s Common Stock, $0.001 par value (the “Common Stock”), consisting of (i) six hundred seventy-five thousand (675,000) shares of Common Stock issuable pursuant to the Company’s 2000 Equity Incentive Plan (the “2000 Plan”), (ii) 100,000 shares of Common Stock issuable pursuant to the Company’s 2000 Non-Employee Directors’ Stock Option Plan (the “Directors Plan”), and (iii) 7,000,000 shares of Common Stock issuable pursuant to the Company’s 2011 Equity Incentive Plan (the “2011 Plan”, and together with the 2000 Plan and the Directors Plan, the “Plans”).

 

In connection with this opinion, we have examined the Registration Statement and related Prospectus, your Certificate of Incorporation and Bylaws, each as currently in effect, the Plans and such other documents, records, certificates, memoranda and other instruments as we deem necessary as a basis for this opinion.  We have assumed the genuineness and authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies thereof, and the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof.

 

Our opinion is expressed only with respect to the federal laws of the United States of America and the General Corporation Law of the State of Delaware. We express no opinion as to whether the laws of any particular jurisdiction other than those identified above are applicable to the subject matter hereof.

 

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Plans, the Registration Statement and related prospectuses, will be validly issued, fully paid, and nonassessable (except as to Shares issued pursuant to certain deferred payment arrangements, which will be fully paid and nonassessable when such deferred payments are made in full).

 

We consent to the filing of this opinion as an exhibit to the Registration Statement.

 

Very truly yours,

 

COOLEY LLP

 

 

By:	/s/ David Peinsipp
	David Peinsipp